{"id":"AIBD-0806","title":"FDA found that the FluChip-8G Influenza A+B Assay, read by trained neural networks, agreed with a cleared molecular test on 984 swab specimens","summary":"In FDA's review of the FluChip-8G assay, sensitivity was 87.9% for influenza A and 100.0% for influenza B against a cleared molecular test, with specificities of 98.8% and 99.8%.","date_observed":"2019-04-22","date_basis":"source publication","date_precision":"day","benefit_status":"intended","source_collection":null,"source_entry":null,"account":"InDevR of Boulder, Colorado, makes the FluChip-8G Influenza A+B Assay, a microarray test for nasal and nasopharyngeal swabs. Seven trained neural networks read the pattern of signals on the microarray and assign influenza types and subtypes. The networks were trained on 3064 microarray images. Swabs were collected from 2013 to 2017 at seven US clinical sites under an influenza surveillance protocol and stored frozen. From June 2017 to July 2018, three US testing sites ran the assay blind on the specimens, and 984 entered the analysis. FDA reviewers report that sensitivity was 87.9% for influenza A and 100.0% for influenza B, with specificities of 98.8% and 99.8%. FDA cleared the assay on 22 April 2019. The invalid rate was 5.9%. The study had only 22 influenza B positives, and it tested archived samples that did not guide care.","category":"aggregate result","unexpected":false,"purpose":"InDevR built the FluChip-8G Influenza A+B Assay to detect influenza A and B in respiratory swabs and to tell seasonal influenza A subtypes from non-seasonal ones.","system":"FluChip-8G Influenza A+B Assay","model_version":null,"developer":"InDevR, Inc.","deployer":"InDevR (clinical study at three US testing sites on archived surveillance swabs)","location":"United States","domain":"Healthcare","segment":null,"benefit_type":"Improved Task Accuracy","work_activities":["4.A.1.b.1"],"taxonomy_note":null,"registry_ids":{},"ratings":[{"group":"organizational","depth":null,"reason":"The assay tested archived swabs against a cleared assay, and no diagnosis or treatment depended on its results."}],"ai_role":{"status":"unassessed","statement":"The study compared the assay's calls with an FDA-cleared molecular assay. It did not compare testing with and without the neural networks."},"evidence":[{"kind":"regulatory document","citation":"U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22.","title":"510(k) Substantial Equivalence Determination Decision Summary, K182513: FluChip-8G Influenza A+B Assay","url":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","date":"2019-04-22","written_by":"independent","quote":"Table 20: FC8G Assay Performance Testing NS and NPS Specimens against the Comparator Assay – Prospective Clinical Study Virus Group (Analyte) Sensitivity Specificity TP/(TP+FN) % 95% CI TN/(TN+FP) % 95% CI Influenza A (Overall) 51/58 87.9% 77.1 – 94.0 915/926 98.8% 97.9 – 99.3"},{"kind":"regulatory document","citation":"U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22.","title":"510(k) Substantial Equivalence Determination Decision Summary, K182513: FluChip-8G Influenza A+B Assay","url":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","date":"2019-04-22","written_by":"independent","quote":"Influenza B(Overall) 22/22 100.0% 85.1 – 100.0 960/962 99.8% 99.2 – 99.9"}],"replication":{"produced_by":["Influenza nucleic acids were extracted from the swabs, amplified and hybridized to the microarray.","A deterministic decision tree combined the neural network outputs with control signals to give each result."],"must_hold":["The specimen comes from a patient with signs and symptoms of respiratory infection.","A non-seasonal influenza A result is confirmed with public health authorities."],"echoes":[]},"paired_incident":null,"headline":"*FluChip-8G* neural networks matched a cleared influenza test","metric":"sensitivity was 87.9% for influenza A and 100.0% for influenza B","comparator":{"against":"An FDA-cleared influenza molecular assay on the same specimens","before":"Comparator assay results (reference)","after":"Sensitivity 87.9% and specificity 98.8% for influenza A, 100.0% and 99.8% for influenza B","basis":"measured","quote":"To assess the clinical performance of the FC8G assay, the prospectively collected archived specimens were thawed and tested with an FDA-cleared influenza molecular assay (the comparator assay) by the reference laboratory, and then blinded and shipped to one of the three participating testing sites.","url":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf"},"later":null,"value":null,"developer_country":"United States","deployer_country":"United States","unrated_because":"The assay was tested on archived swabs whose results guided no care, so no realized outcome is reported for any group.","brief_notes":null,"brief":null,"revisions":[{"date":"2026-10-31","change":"Added the record from the finding of the U.S. Food and Drug Administration.","source":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","editor":"AIBD"}],"confidence":"found","shade":"high","claim_status":"Found by a regulator","claim_basis":"Sources: one independent regulatory document. The cited evidence includes no independent study or report.","case_jurisdictions":["United States"],"profile":{"case_id":"AIBD-0806","catalog_version":"1.0.0","source_fingerprint":"e14d50007a0e743418e0b9e7668ddcc48c88dfd3ecbfc3176512b87ffc7c31b0","collection_refs":[{"collection_id":"aibd","version":"2026-10-31"},{"collection_id":"querist","version":"2026-10-25"}],"source_ids":["AIBD-0806-source-0001","AIBD-0806-source-0002"],"families":{"strategic assessments":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"evaluations":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"monetary observations":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]},"institutional decisions":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"Editorial assignment.","review_state":"not_assessed","coverage":"partial","record_ids":[]}},"fields":{"actors[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"developer":"InDevR, Inc.","deployer":"InDevR (clinical study at three US testing sites on archived surveillance swabs)"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["developer","deployer"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"actors[].ownership_control":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"ai_contribution":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"ai_relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"category":"aggregate result","ai_role":{"status":"unassessed","statement":"The study compared the assay's calls with an FDA-cleared molecular assay. It did not compare testing with and without the neural networks."}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ai_role","category"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].alternatives":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].assessor_date":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].depth":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].display_confidence":{"state":"value_present","value":{"kind":"structured","data":{"confidence":"high","evidence_word":"found","claim_status":"Found by a regulator","basis":"Sources: one independent regulatory document. The cited evidence includes no independent study or report.","interpretation":"Existing display rule preserved; the richer outcome-specific confidence question still needs review."}},"provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].rationale":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"organizational","reason":"The assay tested archived swabs against a cleared assay, and no diagnosis or treatment depended on its results."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"assessments[].rubric_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].status_basis":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"assessments[].target":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"organizational","reason":"The assay tested archived swabs against a cleared assay, and no diagnosis or treatment depended on its results."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"availability":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"brief":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"case_kind":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"case_links[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].evidence_links":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].evidence_strength":{"state":"value_present","value":{"kind":"structured","data":{"answer":"Found by a regulator. Sources: one independent regulatory document. The cited evidence includes no independent study or report.","evidence_word":"found","claim_status":"Found by a regulator"}},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":["AIBD-0806-source-0001","AIBD-0806-source-0002"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"Found by a regulator. Sources: one independent regulatory document. The cited evidence includes no independent study or report.","inferred":false}},"claims[].missingness":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"claims[].proposition":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"cross_border_flows[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"decisions[].action_outcome":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].grounds":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].institution_task":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"decisions[].success_criterion":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"institutional decisions"},"deployment_stage":{"state":"value_present","value":{"kind":"structured","data":{"classification":"laboratory test","answer":"The system was tested in a laboratory. Archived swabs from an influenza surveillance protocol were tested at three US sites before clearance.","scope":"The period and activity described in the case."}},"provenance":{"kind":"source_review","basis":"Editorial assignment.","record_fields":["account","evidence"],"source_refs":["AIBD-0806-source-0001"],"reviewed_on":"2026-10-29"},"review_state":"reviewed","coverage":"complete","display":{"answer":"The system was tested in a laboratory. Archived swabs from an influenza surveillance protocol were tested at three US sites before clearance.","inferred":false}},"economics[].amount":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].costs[]":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].counterfactual":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].currency_price_basis":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].gross_net":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].measure_type":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].period_unit":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].realization":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].recipient_payer":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].return_payback":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"economics[].valuation_method":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"monetary observations"},"evaluations[].ai_uplift":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].comparator":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].design":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].effect":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].exposure":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].id":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].measurement_method":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].metric":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].reproduction_materials":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].setting_sample":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"evaluations[].uncertainty_limitations":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"evaluations"},"external_references[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"follow_up[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"human_oversight":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"id":{"state":"value_present","value":{"kind":"record_fields","fields":{"id":"AIBD-0806"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["id"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"infrastructure_dependencies[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].beneficiaries":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].beneficiary_count":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].benefit_type":{"state":"value_present","value":{"kind":"record_fields","fields":{"benefit_type":"Improved Task Accuracy"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["benefit_type"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].claim":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"InDevR of Boulder, Colorado, makes the FluChip-8G Influenza A+B Assay, a microarray test for nasal and nasopharyngeal swabs. Seven trained neural networks read the pattern of signals on the microarray and assign influenza types and subtypes. The networks were trained on 3064 microarray images. Swabs were collected from 2013 to 2017 at seven US clinical sites under an influenza surveillance protocol and stored frozen. From June 2017 to July 2018, three US testing sites ran the assay blind on the specimens, and 984 entered the analysis. FDA reviewers report that sensitivity was 87.9% for influenza A and 100.0% for influenza B, with specificities of 98.8% and 99.8%. FDA cleared the assay on 22 April 2019. The invalid rate was 5.9%. The study had only 22 influenza B positives, and it tested archived samples that did not guide care.","benefit_type":"Improved Task Accuracy"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["account","benefit_type"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].distribution":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].duration":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].id":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].stakeholder_group":{"state":"value_present","value":{"kind":"record_fields","fields":{"ratings":[{"group":"organizational","reason":"The assay tested archived swabs against a cleared assay, and no diagnosis or treatment depended on its results."}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["ratings"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].status":{"state":"value_present","value":{"kind":"record_fields","fields":{"benefit_status":"intended"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["benefit_status"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"outcomes[].tradeoffs":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"outcomes[].unexpected":{"state":"value_present","value":{"kind":"record_fields","fields":{"unexpected":false,"purpose":"InDevR built the FluChip-8G Influenza A+B Assay to detect influenza A and B in respiratory swabs and to tell seasonal influenza A subtypes from non-seasonal ones."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["unexpected","purpose"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"places[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"location":"United States","developer_country":"United States","deployer_country":"United States"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["location","developer_country","deployer_country"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"purpose":{"state":"value_present","value":{"kind":"record_fields","fields":{"purpose":"InDevR built the FluChip-8G Influenza A+B Assay to detect influenza A and B in respiratory swabs and to tell seasonal influenza A subtypes from non-seasonal ones."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["purpose"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"record_dates":{"state":"value_present","value":{"kind":"record_fields","fields":{"date_observed":"2019-04-22","date_basis":"source publication","date_precision":"day","revisions":[{"date":"2026-10-31","change":"Added the record from the finding of the U.S. Food and Drug Administration.","source":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","editor":"AIBD"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["date_observed","date_basis","date_precision","revisions"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"replication.attempts[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"replication.conditions":{"state":"value_present","value":{"kind":"record_fields","fields":{"replication":{"produced_by":["Influenza nucleic acids were extracted from the swabs, amplified and hybridized to the microarray.","A deterministic decision tree combined the neural network outputs with control signals to give each result."],"must_hold":["The specimen comes from a patient with signs and symptoms of respiratory infection.","A non-seasonal influenza A result is confirmed with public health authorities."],"echoes":[]}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["replication"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"revision_history[]":{"state":"value_present","value":{"kind":"record_fields","fields":{"revisions":[{"date":"2026-10-31","change":"Added the record from the finding of the U.S. Food and Drug Administration.","source":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","editor":"AIBD"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["revisions"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sector":{"state":"value_present","value":{"kind":"record_fields","fields":{"domain":"Healthcare"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["domain"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].access_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"sources[].citation_locator":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"regulatory document","citation":"U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22.","title":"510(k) Substantial Equivalence Determination Decision Summary, K182513: FluChip-8G Influenza A+B Assay","url":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","date":"2019-04-22","written_by":"independent","quote":"Table 20: FC8G Assay Performance Testing NS and NPS Specimens against the Comparator Assay – Prospective Clinical Study Virus Group (Analyte) Sensitivity Specificity TP/(TP+FN) % 95% CI TN/(TN+FP) % 95% CI Influenza A (Overall) 51/58 87.9% 77.1 – 94.0 915/926 98.8% 97.9 – 99.3"},{"kind":"regulatory document","citation":"U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22.","title":"510(k) Substantial Equivalence Determination Decision Summary, K182513: FluChip-8G Influenza A+B Assay","url":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","date":"2019-04-22","written_by":"independent","quote":"Influenza B(Overall) 22/22 100.0% 85.1 – 100.0 960/962 99.8% 99.2 – 99.9"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].id":{"state":"value_present","value":{"kind":"identifiers","identifiers":["AIBD-0806-source-0001","AIBD-0806-source-0002"],"role":"Existing evidence items, in their original order"},"provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"complete"},"sources[].language":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"sources[].relationship":{"state":"value_present","value":{"kind":"record_fields","fields":{"evidence":[{"kind":"regulatory document","citation":"U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22.","title":"510(k) Substantial Equivalence Determination Decision Summary, K182513: FluChip-8G Influenza A+B Assay","url":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","date":"2019-04-22","written_by":"independent","quote":"Table 20: FC8G Assay Performance Testing NS and NPS Specimens against the Comparator Assay – Prospective Clinical Study Virus Group (Analyte) Sensitivity Specificity TP/(TP+FN) % 95% CI TN/(TN+FP) % 95% CI Influenza A (Overall) 51/58 87.9% 77.1 – 94.0 915/926 98.8% 97.9 – 99.3"},{"kind":"regulatory document","citation":"U.S. Food and Drug Administration, Center for Devices and Radiological Health. 510(k) substantial equivalence determination decision summary for FluChip-8G Influenza A+B Assay (K182513). Cleared 2019-04-22.","title":"510(k) Substantial Equivalence Determination Decision Summary, K182513: FluChip-8G Influenza A+B Assay","url":"https://www.accessdata.fda.gov/cdrh_docs/reviews/K182513.pdf","date":"2019-04-22","written_by":"independent","quote":"Influenza B(Overall) 22/22 100.0% 85.1 – 100.0 960/962 99.8% 99.2 – 99.9"}]}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["evidence"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"sources[].upstream_sources":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"strategic_assessments[]":{"state":"unresolved","review_state":"not_assessed","coverage":"partial","family":"strategic assessments"},"summary":{"state":"value_present","value":{"kind":"record_fields","fields":{"summary":"In FDA's review of the FluChip-8G assay, sensitivity was 87.9% for influenza A and 100.0% for influenza B against a cleared molecular test, with specificities of 98.8% and 99.8%.","account":"InDevR of Boulder, Colorado, makes the FluChip-8G Influenza A+B Assay, a microarray test for nasal and nasopharyngeal swabs. Seven trained neural networks read the pattern of signals on the microarray and assign influenza types and subtypes. The networks were trained on 3064 microarray images. Swabs were collected from 2013 to 2017 at seven US clinical sites under an influenza surveillance protocol and stored frozen. From June 2017 to July 2018, three US testing sites ran the assay blind on the specimens, and 984 entered the analysis. FDA reviewers report that sensitivity was 87.9% for influenza A and 100.0% for influenza B, with specificities of 98.8% and 99.8%. FDA cleared the assay on 22 April 2019. The invalid rate was 5.9%. The study had only 22 influenza B positives, and it tested archived samples that did not guide care."}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["summary","account"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"systems[].autonomy_permissions":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].component_role":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].deployment_configuration":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].inputs_outputs":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].model_name":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].model_version":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"systems[].product_name":{"state":"value_present","value":{"kind":"record_fields","fields":{"system":"FluChip-8G Influenza A+B Assay"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["system"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"systems[].provider":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"taxonomy_crosswalks[]":{"state":"unresolved","provenance":{"kind":"curatorial","basis":"Editorial assignment.","record_fields":[],"source_refs":[]},"reason":"This is an explicit unresolved assignment: the sources on record do not settle this question.","review_state":"not_assessed","coverage":"partial"},"title":{"state":"value_present","value":{"kind":"record_fields","fields":{"title":"FDA found that the FluChip-8G Influenza A+B Assay, read by trained neural networks, agreed with a cleared molecular test on 984 swab specimens","headline":"*FluChip-8G* neural networks matched a cleared influenza test"}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["title","headline"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"},"version":{"state":"value_present","value":{"kind":"identifiers","identifiers":["eca917d3ec12a4450878e7de639722971e6c5b499d65d1ed85ad94ccfcd0214d"],"role":"SHA-256 of the complete public record and its assessments"},"provenance":{"kind":"curatorial","basis":"SHA-256 of the public record, its assessments, and its displayed answers and notes, excluding its own identifier and the derived coverage summary.","record_fields":[],"source_refs":[]},"review_state":"record_mapped","coverage":"complete"},"workflow":{"state":"value_present","value":{"kind":"record_fields","fields":{"account":"InDevR of Boulder, Colorado, makes the FluChip-8G Influenza A+B Assay, a microarray test for nasal and nasopharyngeal swabs. Seven trained neural networks read the pattern of signals on the microarray and assign influenza types and subtypes. The networks were trained on 3064 microarray images. Swabs were collected from 2013 to 2017 at seven US clinical sites under an influenza surveillance protocol and stored frozen. From June 2017 to July 2018, three US testing sites ran the assay blind on the specimens, and 984 entered the analysis. FDA reviewers report that sensitivity was 87.9% for influenza A and 100.0% for influenza B, with specificities of 98.8% and 99.8%. FDA cleared the assay on 22 April 2019. The invalid rate was 5.9%. The study had only 22 influenza B positives, and it tested archived samples that did not guide care.","replication":{"produced_by":["Influenza nucleic acids were extracted from the swabs, amplified and hybridized to the microarray.","A deterministic decision tree combined the neural network outputs with control signals to give each result."],"must_hold":["The specimen comes from a patient with signs and symptoms of respiratory infection.","A non-seasonal influenza A result is confirmed with public health authorities."],"echoes":[]}}},"provenance":{"kind":"legacy_record","basis":"Editorial assignment.","record_fields":["account","replication"],"source_refs":[]},"review_state":"record_mapped","coverage":"partial"}},"summary":{"total":91,"addressed":91,"known":27,"reviewed":2,"reviewed_complete":2,"reviewed_partial":0,"record_mapped":25,"review_not_assessed":64,"not_assessed":0,"complete":false,"by_state":{"value_present":27,"not_reported":0,"unresolved":64,"not_assessed":0,"not_applicable":0,"withheld":0,"source_unavailable":0}}},"presentation_version":"f80912cad92b0992edf3799fa0ca7433224ca8850ea50ebc18e70ddf9a40963e"}